ASTRAZEN — Astrazeneca Pharma India Balance Sheet
0.000.00%
Last trade - 00:00- IN₹129.74bn
- IN₹124.46bn
- IN₹10.03bn
Annual balance sheet for Astrazeneca Pharma India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,732 | 2,525 | 3,523 | 4,485 | 5,004 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,048 | 1,152 | 978 | 1,050 | 1,325 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,047 | 5,423 | 6,188 | 7,057 | 8,355 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 817 | 958 | 850 | 767 | 702 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,618 | 7,064 | 7,747 | 8,566 | 9,849 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,590 | 3,272 | 3,035 | 3,327 | 3,839 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 2,610 | 3,419 | 3,185 | 3,452 | 3,962 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Total Equity | 3,008 | 3,644 | 4,562 | 5,114 | 5,887 |
| Total Liabilities & Shareholders' Equity | 5,618 | 7,064 | 7,747 | 8,566 | 9,849 |
| Total Common Shares Outstanding |